Micro-robotic percutaneous targeting of type II endoleaks in the angio-suite - Takeaways - MDSpire

Micro-robotic percutaneous targeting of type II endoleaks in the angio-suite

  • By

  • Gerlig Widmann

  • Johannes Deeg

  • Andreas Frech

  • Josef Klocker

  • Gudrun Feuchtner

  • Martin Freund

  • May 29, 2024

  • 0 min

Share

  • 1

    Abdominal aortic aneurysms affect 1.4% of adults aged 50-84 in the U.S., with endovascular aneurysm repair being the standard treatment for larger aneurysms.

  • 2

    Type II endoleaks occur in 9-30% of EVAR patients, potentially requiring treatment if sac enlargement exceeds 5 mm.

  • 3

    A micro-robotic system was utilized for percutaneous targeting of type II endoleaks when endovascular access was not feasible.

  • 4

    The procedure involved precise imaging and robotic guidance to safely puncture the aneurysm sac and deliver embolization.

  • 5

    Post-treatment imaging confirmed successful embolization by comparing pre- and post-treatment perfused volumes of the endoleak.

Original Source(s)

Micro-robotic percutaneous targeting of type II endoleaks in the angio-suite

  • by Gerlig Widmann, Johannes Deeg, Andreas Frech, Josef Klocker, Gudrun Feuchtner, Martin Freund

  • May 29, 2024

Related Content

FDA Clears AI Guidance Tool for Mitral Repair

AI enhances real-time intraprocedural visualization and navigation.

Who Decides When a Doctor Steps Back?

Cognitive decline, credentialing, and why “I’ll know” often isn’t enough.

Top 10 States for Physician-Owned Hospitals

These 10 states make it more practical for physicians to participate in hospital ownership by aligning statutory structure, corporate practice of medicine rules, and population trends.